Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study

In patients with active cancer and acute venous thromboembolism (VTE), the low-molecular-weight-heparin (LMWH) dalteparin is more effective than vitamin K antagonist (VKA) in reducing the risk of recurrent venous thromboembolism (rVTE) without increasing the risk of bleeding. However, the relative b...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodruff, Seth, Lee, Agnes Y. Y., Carrier, Marc, Feugère, Guillaume, Abreu, Paula, Heissler, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476994/
https://www.ncbi.nlm.nih.gov/pubmed/30859370
http://dx.doi.org/10.1007/s11239-019-01833-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476994/
https://www.ncbi.nlm.nih.gov/pubmed/30859370
http://dx.doi.org/10.1007/s11239-019-01833-w

Ejemplares similares